Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(196 sites) United States
USA Mitchell Cancer Institute ( Site 0014), Mobile, Alabama Banner MD Anderson Cancer Center ( Site 0059), Gilbert, Arizona Banner MD Anderson Cancer Center - University Medical Center Phoenix ( Site 0051), Phoenix, Arizona Arizona Oncology Associates - NAHOA ( Site 8007), Prescott, Arizona Alta Bates Summit Medical Center ( Site 0004), Berkeley, California Moores Cancer Center ( Site 0003), La Jolla, California Care Access - South Pasadena ( Site 0070), Pasadena, California Saint Joseph Hospital ( Site 0026), Denver, Colorado Lutheran Medical Center ( Site 0027), Golden, Colorado Intermountain Health St. Mary's Regional Hospital ( Site 0025), Grand Junction, Colorado Eastern CT Hematology & Oncology Associates ( Site 0033), Norwich, Connecticut Clermont Oncology Center ( Site 0046), Clermont, Florida Florida Cancer Specialists - South ( Site 7001), Fort Myers, Florida Florida Cancer Specialists - East ( Site 7002), West Palm Beach, Florida Parkview Research Center at Parkview Regional Medical Center ( Site 0002), Fort Wayne, Indiana University of Iowa Health Care. ( Site 0017), Waukee, Iowa University of Iowa Health Care. ( Site 0057), Waukee, Iowa Saint Elizabeth Healthcare ( Site 0041), Edgewood, Kentucky Corewell Health-Lemmon Holton Cancer Pavilion ( Site 0011), Grand Rapids, Michigan Regions Hospital ( Site 0042), Saint Louis Park, Minnesota MidAmerica Cancer Care, LLC ( Site 0043), Kansas City, Missouri Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0052), Billings, Montana Summit Medical Group Cancer Center ( Site 0007), Florham Park, New Jersey John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack, New Jersey Roswell Park Cancer Institute ( Site 0023), Buffalo, New York Carolina Oncology Specialists, PA ( Site 0054), Charlotte, North Carolina Southeastern Medical Oncology Center ( Site 0049), Goldsboro, North Carolina Consultants in Medical Oncology and Hematology (CMOH) ( Site 8002), Broomall, Pennsylvania Cancer Care Associates Of York ( Site 0005), York, Pennsylvania Tennessee Oncology-Chattanooga ( Site 0045), Chattanooga, Tennessee Tennessee Oncology, PLLC - Elliston Place Plaza Medical Oncology & Hematology ( Site 0031), Nashville, Tennessee Texas Oncology - Central/South Texas ( Site 8008), Austin, Texas The Center for Cancer and Blood Disorders ( Site 0032), Fort Worth, Texas Texas Oncology - San Antonio ( Site 8006), San Antonio, Texas Texas Oncology - Northeast Texas ( Site 8012), Tyler, Texas University of Virginia Cancer Center ( Site 0040), Charlottesville, Virginia Inova Schar Cancer Institute ( Site 0015), Fairfax, Virginia Virginia Commonwealth University (VCU) Medical Center ( Site 0030), Richmond, Virginia Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010), Spokane, Washington SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical ( Site 0048), Madison, Wisconsin University Hospital and UW Health Clinics ( Site 0006), Madison, Wisconsin Australia
Royal North Shore Hospital ( Site 2806), St Leonards, New South Wales Belgium
AZ Sint-Maarten, Campus Leopoldstraat 2 ( Site 0205), Mechelen, Antwerpen UZ Leuven-Hematology ( Site 0200), Leuven, Vlaams-Brabant Brazil
Hospital 9 De Julho ( Site 2206), São Paulo, São Paulo Instituto Nacional de Câncer - INCA ( Site 2201), Rio de Janeiro Hospital Paulistano-Americas Oncologia ( Site 2202), São Paulo Canada
BC Cancer Kelowna ( Site 0112), Kelowna, British Columbia BC Cancer Victoria ( Site 0109), Victoria, British Columbia William Osler Health System ( Site 0103), Brampton, Ontario The Ottawa Hospital - General Campus ( Site 0102), Ottawa, Ontario McGill University Health Centre ( Site 0106), Montreal, Quebec Centre intégré de santé et de services sociaux du Bas Saint-Laurent- Hôpital régional de Rimouski ( Site 0100), Rimouski, Quebec Chile
FALP-UIDO ( Site 2300), Santiago, Region M. de Santiago Clínica Alemana de Santiago-Unidad de Investigaciones ( Site 2306), Santiago, Region M. de Santiago Bradfordhill-Clinical Area ( Site 2310), Santiago, Region M. de Santiago China
Anhui Provincial Cancer Hospital ( Site 2001), Hefei, Anhui Peking University First Hospital ( Site 2022), Beijing, Beijing Municipality Peking University Third Hospital-Hematology ( Site 2011), Beijing, Beijing Municipality Chongqing University Cancer Hospital ( Site 2041), Chongqing, Chongqing Municipality Southern Medical University Nanfang Hospital-Department of Hematopathology ( Site 2006), Guangzhou, Guangdong Sun Yat-sen University Cancer Center ( Site 2028), Guangzhou, Guangdong Liuzhou People's Hospital ( Site 2029), Liuchow, Guangxi Guangxi Medical University Affiliated Tumor Hospital ( Site 2004), Nanning, Guangxi The Affiliated Hospital of Guizhou Medical University ( Site 2024), Guiyang, Guizhou Hainan General Hospital ( Site 2018), Haikou, Hainan Wuhan Union Hospital ( Site 2015), Wuhan, Hebei Henan Cancer Hospital-hematology department ( Site 2025), Zhengzhou, Henan Colombia
Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 2405), Valledupar, Cesar Department IMAT S.A.S ( Site 2401), Montería, Departamento de Córdoba Fundacion Valle del Lili- CIC-Oncology CIC ( Site 2402), Cali, Valle del Cauca Department Czechia
Fakultni nemocnice Hradec Kralove-IV. interni hematologicka klinika ( Site 0301), Hradec Králové Fakultni nemocnice Olomouc ( Site 0303), Olomouc Vseobecna fakultni nemocnice v Praze-I. Interní klinika - klinika hematologie ( Site 0302), Prague Denmark
Aalborg Universitetshospital, Syd ( Site 0403), Aalborg, North Denmark Roskilde Sygehus-Department of Hematology ( Site 0402), Roskilde, Region Sjælland Odense Universitetshospital-Department of Hematology ( Site 0401), Odense C, Region Syddanmark Germany
Universitaetsklinikum Ulm. ( Site 0601), Ulm, Baden-Wurttemberg VK&K Studien GbR ( Site 0607), Landshut, Bavaria Kliniken Maria Hilf ( Site 0603), Mönchengladbach, North Rhine-Westphalia InVO Institut für Versorgungsforschung in der Onkologie ( Site 0606), Koblenz, Rhineland-Palatinate Universitätsklinikum Halle ( Site 0604), Halle, Saxony-Anhalt Onkologische Schwerpunktpraxis Kurfuerstendamm ( Site 0600), Berlin Greece
Evangelismos General Hospital of Athens ( Site 0700), Athens, Attica General Hospital of Athens "Laiko" ( Site 0704), Athens, Attica University Hospital of Alexandroupolis ( Site 0701), Alexandroupoli, East Macedonia and Thrace University Hospital of Ioannina ( Site 0702), Ioannina Hong Kong
Queen Mary Hospital ( Site 3300), Hong Kong Israel
Rambam Health Care Campus-Hematology and Bone Marrow Transplantation ( Site 1503), Haifa Bnai Zion Medical Center ( Site 1505), Haifa Hadassah Medical Center-Hemato-Oncology ( Site 1500), Jerusalem Galilee Medical Center ( Site 1507), Nahariya Rabin Medical Center ( Site 1504), Petah Tikva Sheba Medical Center-Hemato Oncology ( Site 1501), Ramat Gan Yitzhak Shamir Medical Center. ( Site 1506), Ẕerifin Japan
Nagoya University Hospital ( Site 1907), Nagoya, Aichi-ken Gunma University Hospital ( Site 1903), Maebashi, Gunma Hokkaido University Hospital ( Site 1900), Sapporo, Hokkaido Kobe City Medical Center General Hospital ( Site 1910), Kobe, Hyōgo Tohoku University Hospital ( Site 1901), Sendai, Miyagi Kindai University Hospital ( Site 1909), Sakai, Osaka Shimane University Hospital ( Site 1911), Izumo, Shimane Cancer Institute Hospital of JFCR ( Site 1906), Koto, Tokyo Chiba Cancer Center ( Site 1905), Chiba Kyushu University Hospital ( Site 1914), Fukuoka Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital ( Site 1913), Hiroshima Okayama University Hospital ( Site 1912), Okayama Japanese Red Cross Osaka Hospital ( Site 1908), Osaka Malaysia
University Malaya Medical Centre ( Site 1604), Lembah Pantai, Kuala Lumpur Hospital Pulau Pinang ( Site 1602), George Town, Pulau Pinang Queen Elizabeth Hospital ( Site 1603), Kota Kinabalu, Sabah Mexico
Centro de Infusion Superare ( Site 2602), Mexico City, Mexico City Health Pharma Professional Research S.A. de C.V: ( Site 2608), Mexico City, Mexico City Grupo Médico ASSET ( Site 2611), Mexico City New Zealand
Waikato Hospital-Haematology ( Site 3202), Hamilton, Waikato Region North Shore Hospital-Department of Haematology ( Site 3200), Auckland Aotearoa Clinical Trials ( Site 3201), Auckland Norway
Akershus Universitetssykehus ( Site 0902), Lørenskog, Akershus Sykehuset i Vestfold ( Site 0903), Tønsberg, Vestfold Oslo Universitetssykehus Rikshospitalet-Avdeling for blodsykdommer ( Site 0901), Oslo Peru
Centro Medico Monte Carmelo-Oncology ( Site 2706), Arequipa, Ariqipa Clínica Anglo Americana ( Site 2701), Lima Poland
Pratia MCM Krakow ( Site 1007), Krakow, Lesser Poland Voivodeship Uniwersytecki Szpital Kliniczny nr 1 w Lublinie-Oddział Hematoonkologii-Transplantacji Szpiku i Chem ( Site 1006), Lublin, Lublin Voivodeship Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Kilinka Onkologii I Hematologii ( Site 1004), Warsaw, Masovian Voivodeship Uniwersyteckie Centrum Kliniczne-Klinika Hematologii i Transplantologii ( Site 1011), Gdansk, Pomeranian Voivodeship Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oddział Hematologii i Transplantacji ( Site 1013), Słupsk, Pomeranian Voivodeship Narodowy Instytut Onkologii - Oddzial w Gliwicach ( Site 1000), Gliwice, Silesian Voivodeship Pratia Onkologia Katowice ( Site 1009), Katowice, Silesian Voivodeship Samodzielny Publiczny Zakład Opieki Zdrowotnej MSWiA w Olsztynie-Oddzial Kliniczny Hematologii ( Site 1005), Olsztyn, Warmian-Masurian Voivodeship Portugal
Instituto Português de Oncologia de Lisboa Francisco Gentil ( Site 3103), Lisbon, Lisbon District Champalimaud Foundation ( Site 3102), Lisbon, Lisbon District Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 3107), Vila Nova de Gaia, Porto District Unidade Local de Saude Lisboa Ocidental - Hospital de São Francisco Xavier ( Site 3104), Lisbon Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 3106), Lisbon Instituto Português de Oncologia do Porto Francisco Gentil, EPE ( Site 3100), Porto South Africa
Wits Clinical Research ( Site 1102), Johannesburg, Gauteng Netcare Pretoria East Hospital-Alberts Cellular Therapy ( Site 1101), Pretoria, Gauteng Groote Schuur Hospital-Clinical Haematology ( Site 1100), Cape Town, Western Cape Haemalife ( Site 1105), Kuilsriver, Western Cape Constantiaberg Haematology ( Site 1106), Plumstead, Western Cape Spain
Institut Català d'Oncologia - L'Hospitalet-Haematology Department ( Site 1207), L'Hospitalet Del Llobregat, Barcelona HOSPITAL CLÍNIC DE BARCELONA ( Site 1202), Barcelona, Catalonia HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID ( Site 1209), Pozuelo de Alarcón, Madrid HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA ( Site 1208), Majadahonda, Madrid, Comunidad de hospital universitario de canarias ( Site 1205), San Cristóbal de La Laguna, Santa Cruz De Tenerife Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 1206), Barcelona Hospital Universitario de Salamanca - Complejo Asistencial U-Servicio de Hematologia ( Site 1201), Salamanca Sweden
Karolinska Universitetssjukhuset Solna ( Site 1302), Stockholm, Stockholm County Taiwan
Chang Gung Memorial Hospital at Kaohsiung-Division of Hematology and Oncology ( Site 1702), Kaohsiung City National Cheng Kung University Hospital ( Site 1700), Tainan National Taiwan University Hospital ( Site 1701), Taipei Chang Gung Medical Foundation-Linkou Branch ( Site 1703), Taoyuan District Thailand
Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 1801), Bangkok, Bangkok Chulalongkorn University ( Site 1802), Pathumwan, Bangkok Naresuan University Hospital ( Site 1804), Muang, Changwat Phitsanulok Songklanagarind hospital ( Site 1803), Hat Yai, Changwat Songkhla Maharaj Nakorn Chiang Mai Hospital ( Site 1800), Muang, Chiang Mai Turkey (Türkiye)
Ankara Universitesi Tip Fakultesi Hastanesi-hematology ( Site 1401), Ankara Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1407), Ankara Antalya Egitim ve Arastırma Hastanesi ( Site 1409), Antalya Trakya University Medical Faculty Hospital-Hematology ( Site 1403), Edirne Mega Medipol ( Site 1412), Istanbul Sisli Florence Nightingale Hastanesi ( Site 1411), Istanbul Marmara Universitesi Pendik Egitim Arastirma Hastanesi ( Site 1408), Istanbul Ege Universitesi Hastanesi ( Site 1404), Izmir Ondokuz Mays Üniversitesi ( Site 1410), Samsun United Kingdom
Southmead Hospital ( Site 3010), Bristol, Bristol, City of Royal Lancaster Infirmary ( Site 3012), Lancaster, Lancashire St Bartholomew's Hospital-Centre for Experimental Cancer Medicine ( Site 3006), London, London, City of The Churchill Hospital ( Site 3007), Oxford, Oxfordshire GenesisCare - Bristol ( Site 3011), Bristol, South Gloucestershire GenesisCare - Cambridge ( Site 3001), Newmarket, Suffolk GenesisCare - Windsor ( Site 3002), Windsor, Windsor And Maidenhead Barnet Hospital ( Site 3005), Barnet St James's University Hospital ( Site 3004), Leeds City Hospital, Nottingham University Hospitals NHS Trust ( Site 3003), Nottingham